Japanese Scientists Win Top US Medical Prize for Haemophilia A Breakthrough

Three Japanese researchers have been awarded one of medicine’s most prestigious prizes for their work on haemophilia A (a hereditary bleeding disorder in which the blood cannot clot properly), the New England Journal of Medicine announced. Kunihiro Hattori, Tomoyuki Igawa, and Takehisa Kitazawa received the 2026 Lasker–DeBakey Clinical Medical Research Award in recognition of a prophylactic therapy — a treatment designed to prevent bleeding before it occurs, rather than stopping it after the fact.

The Lasker–DeBakey award is among the most recognised honours in clinical medicine, and recipients have historically gone on to receive Nobel Prizes. The three scientists’ work centres on a new approach to managing haemophilia A, which affects the body’s ability to produce a clotting protein known as factor VIII. Standard treatments have long involved replacing that missing protein, but the therapy developed by Hattori, Igawa, and Kitazawa works differently — it targets the clotting process through an alternative biological pathway.

The New England Journal of Medicine published a Clinical Implications of Basic Research article alongside the announcement, detailing how the scientists’ laboratory discoveries translated into a treatment with real-world patient benefit.

People with haemophilia A experience prolonged or spontaneous bleeding, which without treatment can cause serious joint damage and, in severe cases, life-threatening complications. A preventive therapy — rather than one given only during a bleeding episode — can much change day-to-day life for those living with the condition.

This award has no direct bearing on NHS services in Kent, and the therapy’s availability through the NHS would be subject to separate approval processes by bodies such as the Medicines and Healthcare products Regulatory Agency and the National Institute for Health and Care Excellence. Kent residents with questions about haemophilia or bleeding disorders should contact their GP or call NHS 111.